Reaction

Wound Secretion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,880 reports · 118 co-occurring drugs

As of the last recalculation, Wound Secretion appears in 3,880 FAERS reports alongside 118 co-occurring drug terms. The strongest observed disproportionality signal is DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS (PRR 15.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Diltiazem Hydrochloride Extended-Release Tablets	32	15.2	15.2
Mometasone	46	13.6	13.6
Infliximab-Dyyb	68	12.7	12.7
Fondaparinux Sodium	17	11.3	11.3
Dapsone	22	11.1	11.1
Dalteparin Sodium	21	10.7	10.7
Daspone	19	10.5	10.5
Dapsone Gel, 5%	19	10.5	10.5
Zinc	45	9.9	9.9
Zinc Chloride	45	9.8	9.8
Dabigatran Etexilate	135	9.6	9.6
Dabigatran Etexilate Mesylate	126	9.6	9.6
Cephalexin	38	9.5	9.5
Chlorhexidine Gluconate	16	9.4	9.4
Zinc Gluconate	45	9.3	9.3
Rifampicin	17	9.0	9.1
Clotrimazole	20	8.8	8.8
Cefazolin	14	8.3	8.3
Granisetron Hydrochloride	16	8.2	8.3
Granisetron	16	8.2	8.2
Clindamycin Phosphate	48	7.8	7.8
Cefazolin Sodium	17	7.6	7.6
Drs. Clotrimazole	16	7.5	7.5
Family Wellness Clotrimazole	16	7.5	7.5
Clotrimazole Topical	16	7.4	7.5
Theophylline	15	7.0	7.0
Omalizumab	108	7.0	7.0
Theophylline Anhydrous	16	6.9	7.0
Minocycline	15	6.9	6.9
Alendronate Sodium	125	6.8	6.8
Clindamycin	34	6.5	6.5
Mupirocin	16	6.4	6.4
Mupirocin Calcium	16	6.3	6.3
Moxifloxacin	16	6.1	6.1
Alendronate Sodium Tablet	20	5.8	5.8
Hydrocortisone Sodium Succinate	10	5.7	5.7
Diltiazem Hydrochloride	36	5.6	5.6
Salmeterol Xinafoate	9	5.6	5.6
Metformin Hydrochloride Tablets	59	5.6	5.6
Metformin Hydrochloride Extended-Release Tablets	59	5.6	5.6
Metformin Hydrochloride Tablet	59	5.6	5.6
Metronidazole	65	5.5	5.5
Hydroxyzine	48	5.5	5.5
Metformin Hydrochloride	59	5.4	5.4
Magnesium Sulfate	13	5.4	5.4
Hydrocortisone	87	5.3	5.3
Octreotide Acetate	30	5.3	5.3
Mometasone Furoate	40	5.2	5.2
Acetylcysteine	9	5.1	5.1
Adalimumab	592	5.1	5.1
Magnesium Sulfate In Water For	12	5.1	5.1
Moxifloxacin Hydrochloride	19	5.0	5.1
Cladribine	9	5.0	5.0
Cetiirizine	39	5.0	5.0
Magnesium Sulfate Heptahydrate	12	5.0	5.0
Hydrocortisone Cream	60	4.8	4.8
Atorvastatin Calcium, Film Coated	62	4.8	4.8
Hydrocortisone Acetate	64	4.8	4.8
Anti-Itch	58	4.7	4.7
Anti-Pruritic	58	4.7	4.7
Antipruritic (Anti-Itch)	58	4.7	4.7
Cool Relief Gel With Aloe	58	4.7	4.7
Drs. Hydrocortisone	58	4.7	4.7
Hydrocortisone Continuous Spray	58	4.7	4.7
Hydrocortisone Spray	58	4.7	4.7
Anti-Itch Cream	58	4.7	4.7
Hydrocortisone Lotion	58	4.7	4.7
Hydrocortisone Cream 1%	58	4.7	4.7
Hydrocortisone Cream 1/2%	58	4.7	4.7
Hydrocortisone 1%	58	4.7	4.7
Piperacillin Sodium And Tazobactam Sodium	17	4.7	4.7
Triamcinolone Acetonide Ointment Usp, 0.05%	20	4.6	4.6
Adalimumab-Fkjp	37	4.3	4.3
Metronidazole Topical	38	4.3	4.3
Metolazone	9	4.3	4.3
Tranexamic Acid	7	4.2	4.2
Adalimumab-Adaz	41	4.2	4.2
Dicyclomine Hydrochloride	11	4.2	4.2
Enoxaparin Sodium	44	4.1	4.1
Basiliximab	9	4.1	4.1
Adalimumab-Aaty	36	4.1	4.1
Doxyclycline Hyclate	13	4.1	4.1
Piperacillin Sodium,Tazobactam Sodium	20	4.1	4.1
Rifampin	11	4.1	4.1
Doxycycline Hyclate	50	4.0	4.0
Furosemide	283	4.0	4.0
Doxycycline	50	4.0	4.0
Warfarin Sodium	34	4.0	4.0
Piperacillin And Tazobactam	9	3.8	3.8
Levodopa	8	3.6	3.6
Triamcinolone Acetonide	20	3.5	3.5
Sulfasalazine	50	3.5	3.5
Bupivacaine	6	3.4	3.5
Warfarin	77	3.3	3.3
Linagliptin	11	3.2	3.2
Abiraterone	8	3.2	3.2
Sorafenib	12	3.1	3.1
Canakinumab	6	3.0	3.0
Risankizumab-Rzaa	43	2.8	2.8
Lapatinib	8	2.8	2.8
Isotretinoin	25	2.7	2.7
Upadacitinib	39	2.6	2.6
Rivaroxaban	93	2.4	2.4
Secukinumab	72	2.4	2.4
Rocuronium Bromide	5	2.3	2.3
Trastuzumab	29	2.3	2.3
Golimumab	33	2.1	2.1
Panitumumab	6	2.1	2.1
Pegvaliase-Pqpz	3	2.0	2.0
Ustekinumab	35	1.8	1.8
Crisaborole	3	1.7	1.7
Patiromer	4	1.6	1.6
Abiraterone Acetate	11	1.4	1.4
Bimekizumab	5	1.3	1.3
Velpatasvir And Sofosbuvir	3	1.3	1.3
Pegfilgrastim	22	1.2	1.2
Salicylic Acid	7	0.7	0.7
Adapalene	19	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.